In addition to ESCC, promoter hypermethylation was also found in lung cancer cells, HNSCC, and ovarian cancer [18,36,48] (Figure 5) and associated with PAX9 expression and patient survival. This evidence concerns the gene PAX9 and head and neck squamous cell carcinoma.